Each year, 1.5 million people are given wrong medications that could potentially have serious consequences. Even more shocking, a hospital patient is exposed to at least one medication error per day.
The promising cancer-fighting drug, Gleevec, has encountered its first major hurdle. A study of the drug showed it could be potentially dangerous to the heart and may lead to heart failure.
The Food and Drug Administration (FDA) issued a warning to doctors and patients that some migraine drugs and antidepressants, when used together, might cause a serious health problem known as serotonin syndrome.
A Food and Drug Administration (FDA) debate is heating up over the safety of the antibiotic, Ketek. According to internal FDA e-mails, Ketek’s approval was a mistake and the drug should be taken off the market immediately.
Bristol-Myers Squibb halted sales and production of their commonly used antibiotic, Tequin. The antibiotic, which is used to treat adults for lung, sinus, urinary tract infections, and some sexually transmitted diseases, was linked to diabetes and other health problems associated with blood sugar levels.
After coming under scrutiny for their approval of the antibiotic Ketek, which may cause liver damage in some patients, the Food and Drug Administration (FDA) will reevaluate how they handle clinical drug trials.
The New England Journal of Medicine corrected results of a previously published Vioxx study. This came as a result of discovering Merck used a faulty statistical analysis. The New England Journal of Medicine believed Merck’s findings about Vioxx only being dangerous to people using the drug for 18 months or longer should be removed from their publication.
If Tylenol is your painkiller of choice, you may want to curtail your daily dose to four grams, the equivalent of eight extra-strength tablets. A recent study showed abnormal liver test results in one of five healthy adults who took four grams of Tylenol daily for two weeks. The research raises concerns that even the maximum recommended doses of Tylenol may lead to liver damage.
Thirteen patients taking the Aptivus HIV drug suffered bleeding on the brain, resulting in eight deaths. The Food and Drug Administration (FDA) and Boehringer Ingelheim Pharmaceuticals, the company that makes the drug, report that 6,840 people were participating in clinical studies of Aptivus since it was granted conditional approval to treat HIV last year.